Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2009

01-02-2009 | Research Article

Facilitators for practice change in Spanish community pharmacy

Authors: Miguel A. Gastelurrutia, S. I. Charlie Benrimoj, Carla C. Castrillon, María J. Casado de Amezua, Fernando Fernandez-Llimos, Maria J. Faus

Published in: International Journal of Clinical Pharmacy | Issue 1/2009

Login to get access

Abstract

Objective To identify and prioritise facilitators for practice change in Spanish community pharmacy. Setting Spanish community pharmacies. Method Qualitative study. Thirty-three semi-structured interviews were conducted with community pharmacists (n = 15) and pharmacy strategists (n = 18), and the results were examined using the content analysis method. In addition, two nominal groups (seven community pharmacists and seven strategists) were formed to identify and prioritise facilitators. Results of both techniques were then triangulated. Main outcome measures Facilitators for practice change. Results Twelve facilitators were identified and grouped into four domains (D1: Pharmacist; D2: Pharmacy as an organisation; D3: Pharmaceutical profession; D4: Miscellaneous). Facilitators identified in D1 include: the need for more clinical education at both pre- and post-graduate levels; the need for clearer and unequivocal messages from professional leaders about the future of the professional practice; and the need for a change in pharmacists’ attitudes. Facilitators in D2 are: the need to change the reimbursement system to accommodate cognitive service delivery as well as dispensing; and the need to change the front office of pharmacies. Facilitators identified in D3 are: the need for the Spanish National Professional Association to take a leadership role in the implementation of cognitive services; the need to reduce administrative workload; and the need for universities to reduce the gap between education and research. Other facilitators identified in this study include: the need to increase patients’ demand for cognitive services at pharmacies; the need to improve pharmacist-physician relationships; the need for support from health care authorities; and the need for improved marketing of cognitive services and their benefits to society, including physicians and health care authorities. Conclusion Twelve facilitators were identified. Strategists considered clinical education and pharmacists’ attitude as the most important, and remuneration of little importance. Community pharmacists, in contrast, considered remuneration as the most important facilitator for practice change.
Footnotes
1
Spanish Pharmaceutical Care Forum participants: Health Care Ministry, National Professional Association (Consejo General de Colegios), Spanish Society of Community Pharmacy (SEFaC), Spanish Society of Hospital Pharmacy (SEFH), Spanish Society of Primary Care Pharmacists (SEFAP), Spanish Pharmaceutical Care Foundation, Pharmaceutical Care Research Group of the University of Granada (GIAF-UGR) and The Royal National Academy of Pharmacy.
 
Literature
1.
go back to reference Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill Companies; 1998. ISBN 0-07-012046-3. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill Companies; 1998. ISBN 0-07-012046-3.
2.
go back to reference Martín Calero MJ, Machuca M, Murillo MD, Cansino J, Gastelurrutia MA, Faus MJ. Structural process and implementation programs of pharmaceutical care in different countries. Curr Pharm Des. 2004;10:3969–85. doi:10.2174/1381612043382549.PubMedCrossRef Martín Calero MJ, Machuca M, Murillo MD, Cansino J, Gastelurrutia MA, Faus MJ. Structural process and implementation programs of pharmaceutical care in different countries. Curr Pharm Des. 2004;10:3969–85. doi:10.​2174/​1381612043382549​.PubMedCrossRef
3.
go back to reference Rogers EM. Diffusion of innovations. 5th ed. New York: Free Press; 2003. ISBN 0-7432-2209-1. Rogers EM. Diffusion of innovations. 5th ed. New York: Free Press; 2003. ISBN 0-7432-2209-1.
4.
go back to reference Odedina FT, Segal R, Hepler CD, Lipowski E, Kimberlin C. Changing pharmacists’ practice pattern: pharmacists’ implementation of pharmaceutical care factors. J Soc Adm Pharm. 1996;13:74–88. Odedina FT, Segal R, Hepler CD, Lipowski E, Kimberlin C. Changing pharmacists’ practice pattern: pharmacists’ implementation of pharmaceutical care factors. J Soc Adm Pharm. 1996;13:74–88.
5.
go back to reference Bell HM, McElnay JC, Hughes CM, Woods A. A qualitative investigation of the attitudes and opinions of community pharmacists to pharmaceutical care. J Soc Adm Pharm. 1998;15:284–95. Bell HM, McElnay JC, Hughes CM, Woods A. A qualitative investigation of the attitudes and opinions of community pharmacists to pharmaceutical care. J Soc Adm Pharm. 1998;15:284–95.
6.
go back to reference van Mil JWF, de Boer WO, Tromp ThFJ. European barriers to implementation of pharmaceutical care. Int J Pharm Practice. 2001;9:163–8. van Mil JWF, de Boer WO, Tromp ThFJ. European barriers to implementation of pharmaceutical care. Int J Pharm Practice. 2001;9:163–8.
7.
go back to reference Rossing C, Hansen EH, Krass I. Barriers and facilitators in pharmaceutical care: perceptions and experiences among Danish community pharmacies. J Soc Adm Pharm. 2001;19:55–64. Rossing C, Hansen EH, Krass I. Barriers and facilitators in pharmaceutical care: perceptions and experiences among Danish community pharmacies. J Soc Adm Pharm. 2001;19:55–64.
8.
go back to reference Plaza L, Herrera J. The new challenge of pharmaceutical care: the search of an agreement among professionals. Pharm Care Esp. 2003; 5:160–5. Plaza L, Herrera J. The new challenge of pharmaceutical care: the search of an agreement among professionals. Pharm Care Esp. 2003; 5:160–5.
9.
go back to reference Hidalgo J, Cámara D, Baena MI, Fajardo PC, Martínez-Martínez F. Barriers for implementing pharmacotherapy follow-up in community pharmacies from Granada (Spain). Seguimiento Farmacoterapeutico. 2005; 3(3):144–9. Hidalgo J, Cámara D, Baena MI, Fajardo PC, Martínez-Martínez F. Barriers for implementing pharmacotherapy follow-up in community pharmacies from Granada (Spain). Seguimiento Farmacoterapeutico. 2005; 3(3):144–9.
10.
go back to reference Gastelurrutia MA, Fernandez-Llimos F, Benrimoj SI, Castrillon CC, Faus MJ. Barriers for the implementation of cognitive services in Spanish community pharmacies. Aten Primaria. 2007; 39(9):465–72. Gastelurrutia MA, Fernandez-Llimos F, Benrimoj SI, Castrillon CC, Faus MJ. Barriers for the implementation of cognitive services in Spanish community pharmacies. Aten Primaria. 2007; 39(9):465–72.
11.
go back to reference Roberts AS, Hopp T, Sorensen EW, Benrimoj SI, Chen TF, Herborg H, et al. Understanding practice change in community pharmacy: a qualitative research instrument based on organisational theory. Pharm World Sci. 2003; 25(5):227–34. doi:10.1023/A:1025880012757. Roberts AS, Hopp T, Sorensen EW, Benrimoj SI, Chen TF, Herborg H, et al. Understanding practice change in community pharmacy: a qualitative research instrument based on organisational theory. Pharm World Sci. 2003; 25(5):227–34. doi:10.​1023/​A:​1025880012757.
12.
go back to reference Hopp T, Sørensen EW, Herborg H, Roberts AS. Implementation of cognitive pharmaceutical services in Danish community pharmacies—perceptions of strategists and practitioners. Int J Pharm Pract. 2006;14:37–49. doi:10.1211/ijpp.14.1.0006.CrossRef Hopp T, Sørensen EW, Herborg H, Roberts AS. Implementation of cognitive pharmaceutical services in Danish community pharmacies—perceptions of strategists and practitioners. Int J Pharm Pract. 2006;14:37–49. doi:10.​1211/​ijpp.​14.​1.​0006.CrossRef
14.
go back to reference Gastelurrutia MA, Fernández-Llimós F, García Delgado P, Gastelurrutia P, Faus MJ, Benrimoj SI. Barriers and facilitators to the dissemination and implementation of cognitive services in Spanish community pharmacies. Seguimiento Farmacoterapeutico. 2005;3(2):65–77. Gastelurrutia MA, Fernández-Llimós F, García Delgado P, Gastelurrutia P, Faus MJ, Benrimoj SI. Barriers and facilitators to the dissemination and implementation of cognitive services in Spanish community pharmacies. Seguimiento Farmacoterapeutico. 2005;3(2):65–77.
15.
go back to reference Weber RP. Basic content analysis. 2nd ed. Newbury Park, CA: Sage; 1990. ISBN 0-8039-3863-2. Weber RP. Basic content analysis. 2nd ed. Newbury Park, CA: Sage; 1990. ISBN 0-8039-3863-2.
17.
go back to reference Pickard AS. Towards supporting scholarship in research by clinical pharmacy faculty. Pharm Pract. 2006;4(4):191–4. Pickard AS. Towards supporting scholarship in research by clinical pharmacy faculty. Pharm Pract. 2006;4(4):191–4.
18.
go back to reference Andrés Iglesias JC, Andrés Rodríguez NF, Fornos Pérez JA. Community pharmacy-based research in Spain (1995–2005): a bibliometric study. Pharm Pract. 2007;5(1):21–30. Andrés Iglesias JC, Andrés Rodríguez NF, Fornos Pérez JA. Community pharmacy-based research in Spain (1995–2005): a bibliometric study. Pharm Pract. 2007;5(1):21–30.
19.
go back to reference Armour C, Brillant M, Krass I. Pharmacists’ views on involvement in pharmacy practice research: strategies for facilitating participation. Pharm Pract. 2007;5(2):59–66. Armour C, Brillant M, Krass I. Pharmacists’ views on involvement in pharmacy practice research: strategies for facilitating participation. Pharm Pract. 2007;5(2):59–66.
20.
go back to reference Baena MI, Faus MJ, Marín R, Zarzuelo A, Jiménez-Martín J, Martínez-Olmos J. Problemas de salud relacionados con los medicamentos en un servicio de urgencias hospitalario. Med Clin (Barc). 2005;124:250–5. Baena MI, Faus MJ, Marín R, Zarzuelo A, Jiménez-Martín J, Martínez-Olmos J. Problemas de salud relacionados con los medicamentos en un servicio de urgencias hospitalario. Med Clin (Barc). 2005;124:250–5.
21.
go back to reference Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41:192–9. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41:192–9.
22.
go back to reference Aguas Y, De Miguel E, Fernandez-Llimos F. Pharmacotherapy follow-up as an innovation in community pharmacies of Badajoz (Spain). Seguimiento Farmacoterapeutico. 2005;3:10–6. Aguas Y, De Miguel E, Fernandez-Llimos F. Pharmacotherapy follow-up as an innovation in community pharmacies of Badajoz (Spain). Seguimiento Farmacoterapeutico. 2005;3:10–6.
24.
go back to reference Anonymous. Simpodader 07. Botika XXI. 2007; 10:1–20. Anonymous. Simpodader 07. Botika XXI. 2007; 10:1–20.
25.
go back to reference Huyghebaert T, Farris KB, Volume CI. Barriers to pharmaceutical care. Perceptions of Alberta Community Pharmacists. Can Pharm J. 1999;132(2):36–42. Huyghebaert T, Farris KB, Volume CI. Barriers to pharmaceutical care. Perceptions of Alberta Community Pharmacists. Can Pharm J. 1999;132(2):36–42.
28.
go back to reference Anonimous. [Spanish Medical Association rejects the role of Pharmaceutical Care in National Health Plan]. El Global. 2005; 28-Feb. to 6-Mar. Anonimous. [Spanish Medical Association rejects the role of Pharmaceutical Care in National Health Plan]. El Global. 2005; 28-Feb. to 6-Mar.
29.
go back to reference Anonimous. [73% of physicians consider that Pharmacy should only be involve in dispensing activities]. El Global. 2004; 13-Dec to 19-Dec. Anonimous. [73% of physicians consider that Pharmacy should only be involve in dispensing activities]. El Global. 2004; 13-Dec to 19-Dec.
30.
go back to reference Berringer R, Shibley MC, Cary CC, Pugh CB, Powers PA, Rafi JA. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc. 1999;39:791–7. Berringer R, Shibley MC, Cary CC, Pugh CB, Powers PA, Rafi JA. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc. 1999;39:791–7.
32.
go back to reference Castrillon CC, Gil de San Vicente O, Erauncetamurgil O, Gastelurrutia MA. Influence of facilitating activities taken by members of the staff of a community pharmacy to the implementation of the medication follow-up service. Pharm Pract. 2007;5(supl 1):25–41. Castrillon CC, Gil de San Vicente O, Erauncetamurgil O, Gastelurrutia MA. Influence of facilitating activities taken by members of the staff of a community pharmacy to the implementation of the medication follow-up service. Pharm Pract. 2007;5(supl 1):25–41.
Metadata
Title
Facilitators for practice change in Spanish community pharmacy
Authors
Miguel A. Gastelurrutia
S. I. Charlie Benrimoj
Carla C. Castrillon
María J. Casado de Amezua
Fernando Fernandez-Llimos
Maria J. Faus
Publication date
01-02-2009
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 1/2009
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-008-9261-0

Other articles of this Issue 1/2009

International Journal of Clinical Pharmacy 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine